MULTIPLE MYELOMA COMPREHENSIVE PROFILE
Rs 19,650 Rs 15,000
24 % OFF
THIS PROFILE HELPS TO TRACK THE PROGRESSION OF MYELOMA AND THE RESPONSE TO TREATMENT. DETECTION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PREDICTS OUTCOME, HELPS IDENTIFY IMPENDING RELAPSE AND ENABLES EARLY INTERVENTION, BETTER POST TRANSPLANT SURVEILLANCE AND BETTER CLINICAL MANAGEMENT OF PATIENTS.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
5 ML (3 ML MIN.) SERUM FROM 1 SST AND 3 ML (2 ML MIN.) WHOLE BLOOD IN 1 LAVENDER TOP (EDTA) TUBE. SHIP REFRIGERATED. OVERNIGHT FASTING IS PREFERRED AND 3 ML (1 ML MIN.) BONE MARROW (FIRST PULL ASPIRATE) IN 1 GREEN TOP (SODIUM HEPARIN) TUBE AND 1 OR 2 UNSTAINED BONE MARROW SMEARS TO BE MADE AT SOURCE. MIX THOROUGHLY & SHIP IMMEDIATELY AT 18-22 C OR AT 4-8 C. DO NOT FREEZE. FOLLOWING INFORMATION IS MANDATORY: SAMPLE TIME POINT (CHEMOTHERAPY TIME POINTS); PREVIOUS DIAGNOSTIC IMMUNOPHENOTYPE REPORT; CLINICAL HISTORY TO INCLUDE IF PATIENT IS ON ANTI-CD38 THERAPY; ORIGINAL TRF; DATE AND TIME WHEN SAMPLE WAS DRAWN.
CAPILLARY ELECTROPHORESIS, AGAROSE GEL ELECTROPHORESIS, IMMUNOTURBIDIMETRY,CLIA, DC IMPEDENCE, WITH HYDRODYNAMIC FOCUSSING/ 4D LIGHT SCATTERING, CYANIDE FREE SLS METHOD/COLORIMETRIC, NEPHELOMETRY, FLOW CYTOMETRY
REPORT ON 4TH DAY EVENING 7PM
OVERNIGHT FASTING PREFERRED. FOLLOWING INFORMATION IS MANDATORY: SAMPLE TIME POINT (CHEMOTHERAPY TIME POINTS); PREVIOUS DIAGNOSTIC IMMUNOPHENOTYPE REPORT; CLINICAL HISTORY TO INCLUDE IF PATIENT IS ON ANTI-CD38 THERAPY; ORIGINAL TRF; DATE AND TIME WHEN SAMPLE WAS DRAWN.
